CEA (carcinoembryonic antigen) and CA 19-9, although not sensitive enough for screening and early diagnosis, are the two standard tumor markers used (1) at diagnostic workup (for prognosis) and (2) in post-treatment follow-up (for detection of a relapse). This evidence concerns the gene CEACAM5 and neoplasm.